Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 29, 2013, Pages 9437-9448

  Concheiro, Marta ^a   Anizan, Sebastien ^a   Ellefsen, Kayla ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

LC HRMS; Stability; Synthetic cathinones; Urine

Indexed keywords

CATHINONES; CONFIRMATION METHODS; EXTRACTION EFFICIENCIES; HIGH RESOLUTION MASS SPECTROMETRY; LC-HRMS; LIMITS OF DETECTION; LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRIES; URINE;

BODY FLUIDS; CONVERGENCE OF NUMERICAL METHODS; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHASE SEPARATION;

EXTRACTION;

ALKALOID; CATHINONE;

ARTICLE; EVALUATION STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; SUBSTANCE ABUSE; SYNTHESIS; URINE;

ALKALOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MASS SPECTROMETRY; SUBSTANCE ABUSE DETECTION;

EID: 84890037406     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7386-z     Document Type: Article

References (34)

1. Kelly JP (2011) Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 3(7-8):439-453
2. Strano-Rossi S, Cadwallader AB, de la Torre X, Botre F (2010) Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 24(18):2706-2714
3. United Nations (1971) Covention on psychotropics substances. http://www.unodc.org/pdf/convention-1971-en.pdf. Accessed 6 August 2013
4. Drug Enforcement Administrations (2013) Schedules of controlled substances: placement of methylone into schedule I. Fed Regist 78(71):21818-21825
5. Drug Enforcement Administrations (2012) Drug Abuse Prevention Act 2012 1152b:3187-3139
6. European Monitoring Centre for Drugs and Drug Addiction (2013) Drug profiles: synthetic cathinones. http://www.emcdda.europa.eu/publications/drug- profiles/synthetic-cathinones. Accessed 6 August 2013
7. Gunderson EW, Kirkpatrick MG, Willing LM, Holstege CP (2013) Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use. J Addict Med 7(3):153-162
8. Winstock AR, Mitcheson LR, Deluca P, Davey Z, Corazza O, Schifano F (2011) Mephedrone, new kid for the chop? Addiction 106(1):154-161
9. Kriikku P, Wilhelm L, Schwarz O, Rintatalo J (2011) New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Sci Int 210(1-3):195-200
10. American Association of Poison Control Centers. Alerts: bath salts. http://www.aapcc.org/alerts/bath-salts/. Accessed 6 August 2013
11. Prosser JM, Nelson LS (2012) The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8(1):33-42
12. Meyer MR, Wilhelm J, Peters FT, Maurer HH (2010) Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Anal Bioanal Chem 397(3):1225-1233
13. Pedersen AJ, Reitzel LA, Johansen SS, Linnet K (2013) In vitro metabolism studies on mephedrone and analysis of forensic cases. Drug Test Anal 5(6):430-438
14. Meyer MR, Du P, Schuster F, Maurer HH (2010) Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. J Mass Spectrom 45(12):1426-1442
15. Kamata HT, Shima N, Zaitsu K, Kamata T, Miki A, Nishikawa M, Katagi M, Tsuchihashi H (2006) Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 36(8):709-723
16. Zaitsu K, Katagi M, Kamata HT, Kamata T, Shima N, Miki A, Tsuchihashi H, Mori Y (2009) Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine. Forensic Sci Int 188(1-3):131-139
17. Shima N, Katagi M, Kamata H, Matsuta S, Nakanishi K, Zaitsu K, Kamata T, Nishioka H, Miki A, Tatsuno M, Sato T, Tsuchihashi H, Suzuki K (2013) Urinary excretion and metabolism of the newly encountered designer drug 3,4-dimethylmethcathinone in humans. Forensic Toxicol 31(1):101-112
18. Tyrkko E, Pelander A, Ketola RA, Ojanpera I (2013) In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry. Anal Bioanal Chem. doi: 10.1007/s00216-013-7137-1
19. O'Byrne PM, Kavanagh PV, McNamara SM, Stokes SM (2013) Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system. J Anal Toxicol 37(2):64-73
20. Ojanpera IA, Heikman PK, Rasanen IJ (2011) Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry. Ther Drug Monit 33(2):257-263
21. Thornton SL, Gerona RR, Tomaszewski CA (2012) Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J Med Toxicol 8(3):310-313
22. Torrance H, Cooper G (2010) The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland. Forensic Sci Int 202(1-3):e62-e63
23. Grueninger D, Englert R (2011) Determination of the amphetamine-like designer drugs methcathinone and 4-methylmethcathinone in urine by LC-MS/MS. Ann Toxicol Anal 23(1):7-14
24. Paul BD, Cole KA (2001) Cathinone (Khat) and methcathinone (CAT) in urine specimens: a gas chromatographic-mass spectrometric detection procedure. J Anal Toxicol 25:525-530
25. Marinetti LJ, Antonides HM (2013) Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol 37(3):135-146
26. Bell C, George C, Kicman AT, Traynor A (2011) Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test Anal 3(7-8):496-504
27. Meyer MR, Prosser D, Maurer HH (2013) Studies on the metabolism and detectability of the designer drug beta-naphyrone in rat urine using GC-MS and LC-HR-MS/MS. Drug Test Anal 5(4):259-265
28. Meyer MR, Vollmar C, Schwaninger AE, Wolf E, Maurer HH (2012) New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J Mass Spectrom 47(2):253-262
29. Krouwer JS, Rabinowitz R (1984) How to improve estimates of imprecision. Clin Chem 30(2):290-292
30. Chesher D (2008) Evaluating assay precision. Clin Biochem Rev 29(Suppl 1):S23-S26
31. Springer D, Peters FT, Fritschi G, Maurer HH (2003) New designer drug 4'-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 789(1):79-91
32. Tsujikawa K, Mikuma T, Kuwayama K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H (2012) Degradation pathways of 4-methylmethcathinone in alkaline solution and stability of methcathinone analogs in various pH solutions. Forensic Sci Int 220(1-3):103-110
33. Johnson RD, Botch-Jones SR (2013) The stability of four designer drugs: MDPV, mephedrone, BZP and TFMPP in three biological matrices under various storage conditions. J Anal Toxicol 37(2):51-55
34. Sorensen LK (2011) Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879(11-12):727-736